inhalation

BROVANA® (arformoterol tartrate)

BROVANA® (arformoterol tartrate)

BROVANA Inhalation Solution is a long-acting beta2-adrenergic agonist ( beta2-agonist) indicated for the maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

FLOVENT HFA (fluticasone propionate inhalation aerosol)

FLOVENT HFA (fluticasone propionate inhalation aerosol)

Fluticasone propionate is a synthetic trifluorinated corticosteroid with anti-inflammatory activity. FLOVENT HFA is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients aged 4 years and older.

ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol)

ADVAIR HFA (fluticasone propionate and salmeterol inhalation aerosol)

ADVAIR HFA is indicated for treatment of asthma in adult and adolescent patients aged 12 years and older. ADVAIR HFA should be used for patients not adequately controlled on a long-term asthma control medication such as an inhaled corticosteroid (ICS)

ARCAPTA® NEOHALER®

ARCAPTA® NEOHALER® (indacaterol inhalation powder)

ARCAPTA NEOHALER is a long-acting beta2-adrenergic agonist indicated for: The long term, once-daily maintenance bronchodilator treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.

UTIBRON ® NEOHALER ®

UTIBRON ® NEOHALER ® (indacaterol and glycopyrrolate)

UTIBRON NEOHALER is a combination of indacaterol, a long-acting beta2­ adrenergic agonist (LABA), and glycopyrrolate, an anticholinergic, indicated for the long-term, maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).

Gafacom